Podcast: Artificial Intelligence, GCP Compliance, & Inspection Readiness in Clinical Trials
AI is increasingly being integrated across various industries, demonstrating its versatility and potential. In the biotech sector, it is important to consider how the use of AI might impact integral factors such as GCP compliance and inspection readiness. The incorporation of AI in the clinical trial process brings about a transformative influence on GCP compliance […]
Podcast: Advancing Oncology Research: Regulatory & Development Path for ADCs & RDCs
Join Allucent experts Sugato De, MBE (VP, Regulatory Strategy, Head of MedTech) and Alex MacDonald, PhD (VP, Model Informed Drug Development) in BioPharma Dive’s new podcast. In this episode, we will delve into the innovative realm of antibody drug conjugates (ADCs) and radionuclide conjugates (RDCs) by exploring the tremendous growth potential of these targeted oncology […]
Podcast: Strategic Alliances in the Development and Execution of Pharmacovigilance Strategy
Join Ian Kovacs (Global Head of Pharmacovigilance) for a BioPharma Dive podcast where he examines the pivotal role of strategic partnerships in pharmacovigilance (PV) between biotech companies and CROs. Ian discusses the long-term implications of the traditional study-by-study outsourcing approach versus the formation of a strategic PV alliance and how they can foster a more cohesive, cost-effective and competent PV strategy from clinical […]
Operationalizing Cell and Gene Therapy Trials
Originally published by BioPharmaDive Small and mid-sized biotech companies face unique challenges when bringing novel therapies to market. While many large pharmaceutical companies have the knowledge and in-house talent to clear regulatory hurdles and conduct efficient clinical trials, smaller companies often do not. That’s why small and mid-sized biotechs need to THINK BIG when working to […]
Why Multinational Clinical Trials are Key to Bringing Novel Therapies to Patients
Originally published by BioPharmaDive Small and mid-sized biotech companies face unique challenges when bringing novel therapies to market. While many large pharmaceutical companies have the knowledge and in-house talent to clear regulatory hurdles and conduct efficient clinical trials, smaller companies often do not. That’s why small and mid-sized biotechs need to THINK BIG when working to […]
Defining the Regulatory Roadmap for Product Success
Originally published by BioPharmaDive Small and mid-sized biotech companies face unique challenges when bringing novel therapies to market. While many large pharmaceutical companies have the knowledge and in-house talent to clear regulatory hurdles and conduct efficient clinical trials, smaller companies often do not. That’s why small and mid-sized biotechs need to THINK BIG when working […]